BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12520517)

  • 1. Vitamin D and autoimmune diabetes.
    Zella JB; DeLuca HF
    J Cell Biochem; 2003 Feb; 88(2):216-22. PubMed ID: 12520517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.
    Adorini L; Penna G; Giarratana N; Uskokovic M
    J Cell Biochem; 2003 Feb; 88(2):227-33. PubMed ID: 12520519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and type 1 diabetes mellitus: state of the art.
    Mathieu C; Badenhoop K
    Trends Endocrinol Metab; 2005 Aug; 16(6):261-6. PubMed ID: 15996876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D physiology.
    Lips P
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor.
    Gysemans C; van Etten E; Overbergh L; Giulietti A; Eelen G; Waer M; Verstuyf A; Bouillon R; Mathieu C
    Diabetes; 2008 Jan; 57(1):269-75. PubMed ID: 17959935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D insufficiency--possible etiologic factor of autoimmune diseases].
    Jørgensen SP; Bartels LE; Agnholt J; Glerup H; Nielsen SL; Hvas CL; Dahlerup JF
    Ugeskr Laeger; 2007 Oct; 169(43):3655-60. PubMed ID: 17967265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system.
    Mathieu C; van Etten E; Decallonne B; Guilietti A; Gysemans C; Bouillon R; Overbergh L
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):449-52. PubMed ID: 15225818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse.
    Hawa MI; Valorani MG; Buckley LR; Beales PE; Afeltra A; Cacciapaglia F; Leslie RD; Pozzilli P
    Horm Metab Res; 2004 Sep; 36(9):620-4. PubMed ID: 15486813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities.
    Baeke F; van Etten E; Gysemans C; Overbergh L; Mathieu C
    Mol Aspects Med; 2008 Dec; 29(6):376-87. PubMed ID: 18621414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.
    Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E
    Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and vitamin D: an update.
    VanAmerongen BM; Dijkstra CD; Lips P; Polman CH
    Eur J Clin Nutr; 2004 Aug; 58(8):1095-109. PubMed ID: 15054436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of vitamin D deficiency on diabetes and cardiovascular risk.
    Baz-Hecht M; Goldfine AB
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):113-9. PubMed ID: 20150805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.
    Van Etten E; Decallonne B; Verlinden L; Verstuyf A; Bouillon R; Mathieu C
    J Cell Biochem; 2003 Feb; 88(2):223-6. PubMed ID: 12520518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-dihydroxycholecalciferol: endocrinology meets the immune system.
    van Etten E; Decallonne B; Mathieu C
    Proc Nutr Soc; 2002 Aug; 61(3):375-80. PubMed ID: 12230797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: vitamin D and inflammatory bowel disease.
    Lim WC; Hanauer SB; Li YC
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):308-15. PubMed ID: 16265284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological functions of the vitamin D endocrine system.
    Hayes CE; Nashold FE; Spach KM; Pedersen LB
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):277-300. PubMed ID: 12887108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
    Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK
    J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of autoimmune diseases by the vitamin D endocrine system.
    Adorini L; Penna G
    Nat Clin Pract Rheumatol; 2008 Aug; 4(8):404-12. PubMed ID: 18594491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.